CLINICAL_TRIALS
trial_result
· 2010-03-01
Clinical Trial Update: Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia [Phase 2]
Summary
Phase 2 trial evaluating Bryostatin-1 in combination with cytarabine for relapsed acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Leukemia | Phase 2 | Status: COMPLETED